African histoplasmosis is defined as the fungal infection caused by Histoplasma capsulatum var. duboisii (Hcd). Studies focused on distinguishing Hcd and H. capsulatum var. capsulatum (Hcc), which coexist in Africa, are scarce or outdated, and African strains are continuously underrepresented. In this work, 13 cases of African patients with histoplasmosis diagnosed in the Spanish Mycology Reference Laboratory have been reviewed showing that 77% had disseminated disease and AIDS as underlying disease although Hcd infection has been classically considered a rare presentation in AIDS patients. Strains isolated from these patients and other clinical and reference strains were studied by assessing classical identification methods and performing a three-loci multi-locus sequence analysis (MLSA). Classical identification methods based on biochemical tests and measurement of yeast size proved to be useless in distinguishing both varieties. The MLSA defined an African cluster, with a strong statistical support, that included all strains with African origin. Finally, mating type was also determined by using molecular methods revealing an unequal mating type distribution in African strains. In conclusion, historical statements and classical identification methods were useless to distinguish between varieties, whereas molecular analyses revealed that all strains with African origin grouped together suggesting that traditional classification should be revised. Further investigation is required in order to unravel traditional concepts about Hcd infection and support results obtained in this work.
Introduction
Histoplasmosis is an endemic mycosis caused by the dimorphic fungus Histoplasma capsulatum. The fungus is present mainly in the Americas, West Africa, and some regions of Asia. 1 Classically, two varieties have been reported to be pathogenic to humans: Histoplasma capsulatum var.
capsulatum (Hcc) 2 and Histoplasma capsulatum var.
duboisii (syn. Histoplasma duboisii) (Hcd). 3 Hcd is present exclusively in the African continent where both varieties coexist. 4 The clinical picture associated with Hcd infection is different from that associated with Hcc. Whereas Hcc primarily has been described as affecting lungs, Hcd infection involves mainly skin and subcutaneous tissues, rarely lungs. 5 In contrast to Hcc, human immunodeficiency virus (HIV) and Hcd coinfection has been described to be rare, 6, 7 which may be due to a problem of under-reporting or underrecognition. 8 To date, pathogenesis, epidemiology, prevalence, and mortality due to the African variety of the fungus remain unclear, due the scarcity of data and also similarities with other fungal species such as Emmonsia spp. 9 With increased rates of travel and immigration from endemic areas, 10 ,11 imported cases are described more frequently, mainly in countries receiving immigration from Africa such as Spain and France. 12, 13 However, differentiation between both varieties of the fungus has rarely been performed in isolated clinical strains and molecular analyses have been focused on comparing ITS sequences to NCBI database where it is poorly represented 14 The aim of this study was to better understand epidemiology and clinical characteristics of African histoplasmosis and to investigate classical and molecular methods that could help to properly differentiate both varieties of the fungus in clinical setting. Cases from African patients diagnosed at the Spanish Mycology Reference Laboratory were retrospectively analyzed and a deep molecular analysis was performed with strains isolated from these patients in order to easily identify the varieties present in Africa.
Methods

Patients
A total of 13 histoplasmosis patients, immigrants or travelers from Africa, were diagnosed in the last 10 years in the Spanish National Center for Microbiology (Majadahonda, Spain) ( Table 1) . Diagnosis was performed by classical methods and a quantitative real-time polymerase chain reaction assay (qPCR). 21 In 
Analysis of yeast size by flow-cytometry
Fourteen strains were used in this study and analyzed by flow-cytometry to measure yeast size. In BSL3 facilities, yeast cells were collected from the surfaces of ML-Gema cultures after 14 days of incubation at 30
• C, placed in 1 ml of phosphate-buffered saline (PBS) and adjusted to 1 × 10 10 cells/ml. Subsequently, after a centrifugation at 13.000 x g for 5 min, the pellet was resuspended in 100 μl of paraformaldehyde (PAF) 4% for 30 min. To ensure a complete killing of fungi, yeast fixed suspensions were also cultured in SDA tubes at 30
• C for 2 months. Once inactivation was verified, yeast suspensions were conserved at 4
• C in a BSL2 laboratory. The propidium iodide (PI) staining protocol was developed as described by other authors. 24 Yeast cell sizes were measured in duplicate experiments using a FacsCalibur flow cytometer (BD Biosciences, Woburn, MA, USA) and a sorting gate was used to avoid size measurement of duplexes and cell aggregates. Flow-cytometry data were processed using FlowJo software (Tree Star, Inc., Ashland, OR, USA). GraphPad Prism version 6.00 for Windows (GraphPad Software, La Jolla, CA, USA) was used for statistical analysis.
DNA isolation and target amplification
DNA extraction from fungal cultures was performed under BSL3 containment using the Wizard SV Genomic DNA Purification System (Promega Corporation, Madison, WI, USA) following manufacturer instructions. DNA obtained was quantified and its quality was checked using Nanodrop 2000 spectrophotometer (NanoDrop Technologies, Inc., Wilmington, DE, USA).
PCRs were performed in a 50-μl final volume reaction containing: 1 μM of each primer, 0.2 μM deoxynucleoside triphosphate (Roche Diagnostics, Madrid, Spain), 5 μl of PCR 10x buffer II (Applied Biosystems, Foster City, CA, USA), 2 mM MgCl2, 1.5 U of Taq DNA polymerase (Applied Biosystems, USA) and 30-50 ng of genomic DNA. PCR amplification was carried out in a GeneAmp PCR System 9700 (Applied Biosystems, USA) and PCR conditions were as follows: an initial step of 95
• C for 5 min followed by 35 cycles of 95
• C for 30 s, an annealing temperature that varied with each target (Table S2) for 45 s and 72
• C for 2 min with a final step at 72
• C for 5 min. PCR products were resolved by electrophoresis on ethidium bromide stained agarose gels and were purified using Illustra Exoprostar 1-step (GE Healthcare Life Science, Little Chalfont, UK). In the case of mating type characterization, genotype discrimination was performed by excluding either MAT1-1 or MAT1-2 amplification in the agarose gel.
Sequence analysis
Sequencing was carried out with the Big-Dye terminator cycle sequencing kit (Applied Biosystems, USA) following manufacturer instructions, in an ABI DNA Analyzer 3730xl (Applied Biosystems, USA) using the same PCR amplification primers. Sequences were generated from both strands and edited using Lasergene software package (DNAStar Inc., Madison, WI, USA). Multiple sequence alignments were carried out by MUSCLE algorithm 25 implemented in MEGA software v 5.2. 26 The selection of nucleotide substitution models for sequence alignments was performed using jModelTest software v. 2.1.4 27 and phylogenetic trees from individual and concatenated alignments were inferred based on a maximum likelihood (ML) approach with 1,000 bootstrap replications for testing branch support using default settings.
Nucleotide sequence accession numbers
Sequences of products from PCRs of all genomic targets analyzed in this study were deposited in GenBank under the following range of accession numbers: KX645968-KX646167 (Table S3) .
Results
Epidemiological characteristics and diagnosis of African patients
Thirteen patients from Africa were diagnosed in the last decade in the Spanish Mycology Reference Laboratory ( Table 1 ). The median age of patients was 47 (22-67), and most of them were men (10/13). All but one fulfilled proven (n = 11) or probable (n = 1) criterion. For patient 2, there were only clinical suspicions and positive qPCR results, and it was classified as possible. All but two were immigrants coming from Sub-Saharan regions, and 11 out of 13 were immunocompromised patients, most of them with AIDS as underlying disease (10/11) and disseminated disease. There were two immunocompetent patients: one of them developed a cutaneous primary infection 14 and the other was a Spanish traveler who developed acute pulmonary histoplasmosis. Skin lesions were present only in three patients. The fungus was isolated in culture in 54% of the cases (7/13) and was observed by histopathological examination in 31% of them (4/13). Serological tests were positive in four out of seven sera tested (57%), and qPCR was positive in tested patients. qPCR was positive in 100% of biopsy, respiratory, adenopathy, and plasma samples tested, but sensitivity decreased in samples of bone marrow (50%) followed by serum (33%), and no DNA was detected in any of the three blood samples tested (Table 1) . At the moment of diagnosis, amplicon sequencing was performed, but ITS1 rDNA sequence did not allow differentiating between varieties. Strains isolated from patients 5, 8, 11, 12, and 13 were available and included in molecular studies.
Urease test
All mycelia forms of H. capsulatum strains (n = 50) tested for urease activity were urease positive. There was no correlation between urease test results and H. capsulatum varieties.
Yeast size assessment by flow-cytometry
Yeast sizes from 14 H. capsulatum strains were defined by measuring forward angle light scattering in a flow cytometer. This parameter is proportional to the cross-sectional area of the cells, and thus reflects their size. As shown in Figure 1 , CNM-CM 7001 (AS) and CBS 175.57 (Hcd), both with African origin, showed larger sizes, whereas CNM-CM 2721 (Hcc) exhibited the lowest size measurement. However, between these values, yeast size varied among all the rest of H. capsulatum strains not correlating with the variety to which they belong or their geographical origin. Moreover, a Mann-Whitney test comparing means of American and African strains yeast sizes was performed, and no significant difference was observed (P = 0.1206).
Multi-locus sequence analysis (MLSA) and phylogeny DNA sequences of three genomic regions of 50 H. capsulatum strains (Table S1 ) were used to explore the genetic variability among them: ITS1-5.8S-ITS2-D1D2 rDNA region, Figure 2 and Figure 3 . Of note, we were not able to achieve strain CNM-CM 8013 yeast-phase conversion therefore it was not included in this analysis.
a portion of RPB1 gene, which encodes the largest subunit of RNA polymerase II, and a region of gene OLE, which encodes delta-9 fatty acid desaturase enzyme. For ITS-5.8S-ITS2-D1D2 alignment (1176 bp) Tamura-Nei (Trn) model 28 was selected according to results obtained from jModelTest analysis, whereas for RPB1 (839 bp) and OLE alignments (419 bp) Kimura 2-parameter (K80) model 29 was chosen. African strains grouped together in all loci analyzed, but only in the OLE tree showed bootstrap support (90%). However, one Hcc strain with African origin (CBS 287.54) grouped within this group in all inferred trees (Fig.  S1 ). Data for the three loci were combined into one phylogenetic analysis (2434 bp) (Fig. 2) . African clade was supported by a bootstrap value of 97%, although the South African Hcc strain CBS 287.54 remained grouped within this African cluster.
Frequency and genetic diversity of MAT1 locus
Mating type was analyzed for each strain: 46% (23/50) of the total number of strains showed MAT1-1 genotype, whereas 54% (27/50) corresponded to the MAT1-2 genotype. Regarding H. capsulatum varieties, in Hcc strains, an equal distribution of mating types was found, as 50% (21/42) of Hcc strains showed MAT1-1 sequences and the remaining 50% (21/42) were described as having MAT1-2 genotype. In contrast, among African strains, most of them were MAT1-2 (75%, 6/8). ML trees were inferred from these alignments based on the K80 model for MAT1-1 sequences (390 bp) and the Hasegawa-Kishino-Yano (HKY) model 30 for MAT1-2 sequences (534 bp). As a result, African strains with MAT1-2 sequences (n = 6) formed a defined group with a strong bootstrap support (99%). In contrast, those African strains showing MAT1-1 genotype were underrepresented (n = 2) but grouped in the same cluster as the Hcc strain with African origin CBS 287.54 (Fig. 3) .
Discussion
African histoplasmosis is defined as the disease caused by H. capstulatum var. duboisii, although both varieties of the fungus are present in Africa. Due to immigration and travel the prevalence of imported histoplasmosis from Africa has increased in some nonendemic regions of Europe. The identification of the variety causing the infection is challenging in these areas because the data regarding clinical presentation of patients and microbiological characteristics of the fungus are based on outdated and limited by small sample sizes studies. 5, 15 Moreover, open access sequence databases contain few entries of Hcd sequences for warranting a proper molecular identification. Finally, clinical data regarding African patients in Europe are scarce, 8, 31, 32 and frequently, identification of varieties has been based on histopathological observations and yeast size. In contrast to classical clinical features about Hcd infection, the vast majority of African patients included in this study (10/13) had AIDS and disseminated disease, whereas skin lesions were present only in three patients. However, it should be taken into account that, due to the limited number of patients, it could be a bias in clinical forms observed as most patients had AIDS as underlying disease.
Strains isolated from patients were studied along with other CNM-CM clinical strains and strains from international culture collections. First, classical methods to differentiate varieties were assessed: (i) urease test was performed resulting in all strains analyzed being urease positive, indicating the pointlessness of this test as already described by other authors 33, 34 and (ii) yeast sizes were measured by using flow-cytometry but no significant differences were found among them. Size measurement was performed in vitro using specific culture conditions and additional studies should be performed in order to confirm these results. Then, an MLSA based on amplifying, sequencing, and analyzing three different genomic regions was performed. The three chosen regions were: the ITS1-5.8S-ITS2-D1D2 region of rDNA, as it is considered the universal barcode marker for fungi 35 ; the RPB1 gene, described as an alternative to ITS barcoding and included in the AFToL (Assembling the Fungal Tree of Life) project 36 ; and the OLE gene which has demonstrated to provide information related to geographical origin of H. capsulatum strains. 37 When data from the three loci were combined in a single phylogenetic analysis, an African clade achieved strong statistical support (96% of bootstrap value), but the South African Hcc CBS 287.54 isolate remained included in this group showing that it is genetically related with Hcd and AS strains included in this work. Finally, mating type was identified for all strains included in the assay by using molecular methods. In this study, the mating type ratio was near 1:1 in contrast to previous studies that showed MAT1-2 prevalence in clinical samples. 38 In addition, although Hcc strains showed identical distribution of the two mating types, African isolates exhibited a ratio of 1:3 with 1-2 mating type being strongly predominant. When analyzing MAT1-1 and MAT1-2 sequences, all African strains grouped with strong statistical support including the South African Hcc CBS 287.54 isolate. This is the first time that mating type is studied in African strains by using molecular methods and it should be further investigated in a bigger number of African strains in order to provide more information to support results found in this work.
Taking the results together, all strains with African origin grouped together in performed molecular analyses. Strain CBS 287.54 always grouped between these strains, although it was classified at CBS as Hcc. This suggests that it could be erroneously classified, and further studies should be performed in order to confirm its identification.
In conclusion: (i) historical statements about clinical characteristics of the infection caused by H. capsulatum var. duboisii were useless to distinguish between varieties in our clinical setting, (ii) classical microbiological methods were not conclusive either, and (iii) MLSA allowed defining an African cluster that included Hcc and Hcd strains from international collections and all the strains isolated from patients, supporting previous studies 18, 19 and suggesting that classical classification should be revised. Despite the limitations of this study due to a low sample size of African strains, to the best of our knowledge this is the first research that analyzes clinical characteristics of African histoplasmosis patients and includes strains isolated from these patients in a wide molecular analysis. Further investigation on clinical, microbiological, and molecular features of African histoplasmosis is essential to unravel established classical concepts about the infection.
